SNCA and Parkinson disease: Consistent with these findings, in vitro and in vivo studies have confirmed the key role of CMA in α-synuclein turnover and intracellular levels [58,61,62,64], and decreased levels of CMA markers have been reported in postmortem nigral samples from PD patients [65,66].